Diabetes: Clinical inertia - A barrier to effective management of T2DM

Nature Reviews Endocrinology

Volumn 9, Issue 11, 2013, Pages 635-636

  Lovshin, Julie A ^a   Zinman, Bernard ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INCRETIN; INSULIN; ORAL ANTIDIABETIC AGENT; PROTEIN INHIBITOR; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; SULFONYLUREA; SYNTHETIC INSULIN; UNCLASSIFIED DRUG;

ARTICLE; CALORIE; DIABETES CONTROL; DIET; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEDENTARY LIFESTYLE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 84886597803     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.185     Document Type: Article

References (10)

1. Wild, S., Roglic, G., Green, A., Sicree, R. & King, H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053 (2004).
2. Ogden, C. L., Carroll, M. D., Kit, B. K. & Flegal, K. M. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief. 82, 1-8 (2012).
3. Khunti, K., Wolden, M. L., Thorsted, B. L., Andersen, M. & Davies, M. J. Clinical inertia in people with type 2 diabetes: A retrospective cohort study of more than 80,000 people. Diabetes Care http://dx.doi.org/10.2337/dc13- 0331.
4. Tahrani, A., Bailey, C., Del Prato, S. & Barnett, A. Management of type 2 diabetes: New and future developments in treatment. Lancet 378, 182-197 (2011).
5. Holman, R. R., Paul, S. K., Bethel, M. A., Mathews, D. R. & Neil, H. A. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577-1589 (2008).
6. Shah, B. R., Hux, J. E., Laupacis, A., Zinman, B. & van Walraven, C. Clinical inertia in response to inadequate glycemic control: Do specialists differ from primary physicians? Diabetes Care 28, 600-606 (2005).
7. Inzucchi, S. E. et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55, 1577-1596 (2012).
8. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 37 (Suppl. 1), S1-S212 (2013).
9. Zinman, B. Initial combination therapy for type 2 diabetes mellitus: Is it ready for prime time? Am. J. Med. 124 (Suppl. 1), S19-S34 (2011).
10. Miccoli, R., Penno, G. & Del Prato, S. Multidrug treatment of type 2 diabetes: A challenge for compliance. Diabetes Care 34 (Suppl. 2), S231-S235 (2011).